US CDC Panel Supports Moderna, Janssen COVID Vaccine Boosters But Strips Out Preference Language For Homologous Dosing

 
• By Sue Sutter

ACIP pushes back on proposed policy recommendation that the same product used for the primary regimen should be used for the booster, saying risk/benefit and other considerations necessitate more flexibility afforded by 'mix and match' approach.

Mix and match
ACIP members liked the flexibility offered by being able to mix and match a booster dose with a different primary vaccination series. • Source: Alamy

More from Vaccines

More from Pink Sheet